Počet záznamov: 1
letrozol
SYS d000077289 LBL 00000nz--a2200181n--4500 005 20250606222643.7 008 190101|||anznnbabn-----------|-a|a------ 040 $b slo $a BA006 $d BA006 065 $a D02.626.300 065 $a D03.383.129.799.638 066 $a 01 $c 03 150 $a letrozol $x AA $x AD $x AE $x AG $x AI $x AN $x BL $x CF $x CH $x CL $x CS $x EC $x HI $x IM $x IP $x ME $x PD $x PK $x PO $x RE $x SD $x ST $x TO $x TU $x UR $2 slo 450 $w v $a 4,4'-(1H-1,2,4-triazol-1-yl-metylén)-bis(benzonitril) $2 slo 450 $w v $a Femara $2 slo 450 $w v $a Fémara $2 slo 550 $7 sllk_us_auth*d000970 $Y Antineoplastic Agents $w P $a antineoplastiká 550 $7 sllk_us_auth*d047072 $Y Aromatase Inhibitors $w P $a inhibítory aromatázy 665 $a 2019 (1991) $2 eng 680 9-
$i A triazole and benzonitrile derivative that is a selective non-steroidal aromatase inhibitor, similar to ANASTROZOLE. It is used in the treatment of metastatic or locally advanced breast cancer in postmenopausal women. $2 eng 750 -2
$a Letrozole $2 eng 980 $x M
Počet záznamov: 1